Published November 15, 2022 | Version v.1
Journal article Restricted

Clinical Profile and Outcome of 806 Pediatric Oncology Patients Treated With Radiotherapy at the Serbian National Cancer Center

  • 1. University of Belgrade, Serbia; Pediatric Radiation Oncology Department Institute of Oncology and Radiology of Serbia
  • 2. Pediatric Radiation Oncology Department. Institute of Oncology and Radiology of Serbia
  • 3. University of Belgrade, Serbia; Pediatric Radiation Oncology Department Institute of Oncology and Radiology of Serbia
  • 4. University of Belgrade, Serbia; Pediatric Oncology Department; Neuro-Oncology Department, Clinic of Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia
  • 5. University of Belgrade, Serbia; Institute of Epidemiology, University of Belgrade, Faculty of Medicine.
  • 6. Pediatric Oncology Department.
  • 7. Pediatric Oncology Department, Institute of Oncology and Radiology of Serbia
  • 8. Department of Medical Physics, Institute of Oncology and Radiology of Serbia
  • 9. Pediatric Radiation Oncology Department.
  • 10. University of Belgrade, Serbia; Pediatric Radiation Oncology Department. Institute of Oncology and Radiology of Serbia

Description

Abstract

Radiotherapy plays an important role in the multimodal treatment of childhood cancer. Our objective was to provide an analysis of pediatric oncology patients treated with radiotherapy in a national referral institution in Serbia. A retrospective chart review of children treated with radiotherapy between January 2007 and July 2018 was conducted. Of the 806 patients who were identified, 767 formed the basis of this study. CNS tumors (31.2%) were the most common tumors followed by leukemias (17.3%) and bone tumors (14.3%). The most common indication for radiotherapy was in adjuvant setting (69.1%). Anesthesia or sedation was performed on 115 patients. The 5-year and 10-year overall survival rates were 65.7% and 62.1%, respectively. A significant difference in survival in relation to tumor type was seen. The best survival rates were obtained in patients with retinoblastoma, followed by lymphomas and nephroblastoma, while patients with bone sarcomas had the worst survival. The intent of radiotherapy treatment was also a parameter associated with survival. Patients treated with palliative and definitive intent lived shorter than patients treated with prophylactic and adjuvant intent. Our study showed that good treatment outcomes can be achieved in specialized centers with an experienced team of professionals who are dedicated to pediatric oncology.

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Request access

If you would like to request access to these files, please fill out the form below.

You need to satisfy these conditions in order for this request to be accepted:

Access to the full text article with institutional password only.

You are currently not logged in. Do you have an account? Log in here

Additional details

Related works

Is documented by
36730662 (PMID)
Is part of
1077-4114 (ISSN)